<DOC>
	<DOCNO>NCT01260324</DOCNO>
	<brief_summary>The objective study : ( 1 ) evaluate natural history non-arteritic anterior ischemic optic neuropathy ( NAION ) ; ( 2 ) estimate population incidence NAION ; ( 3 ) identify potential risk factor NAION .</brief_summary>
	<brief_title>Epidemiology Study Non-arteritic Anterior Ischemic Optic Neuropathy ( NAION )</brief_title>
	<detailed_description>The study population consist member Ingenix Normative Health Informatics ( NHI ) Database 01/01/2003 12/31/2007 , 18 year age old least 183 day continuous enrollment database without doctor visit associate diagnosis ischemic optic neuropathy 183 day prior cohort entry . From study population , patient claim associate ischemic optic neuropathy diagnosis code identify potential NAION case ( n = 3,732 ) . From potential NAION case , definite possible NAION case identify use medical record review claim algorithm ( n=1,283 ) . From study population , patient without claim associate ischemic optic neuropathy diagnosis code randomly select control ( n = 20,000 )</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<criteria>Member Ingenix Normative Health Informatics ( NHI ) Database 01/01/2003 12/31/2007 18 year age old Had least 183 day continuous enrollment database No doctor visit associate diagnosis ischemic optic neuropathy 183 day prior cohort entry Less 18 year age Less 183 day continuous enrollment database At least one doctor visit associate diagnosis ischemic optic neuropathy 183 day prior cohort entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Phosphodiesterase type 5 inhibitor</keyword>
	<keyword>non-arteritic anterior ischemic optic neuropathy</keyword>
	<keyword>descriptive epidemiology study</keyword>
</DOC>